Ahalya K. Malachira

发表

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Scott A. Prentice, Tom Michael Mitchell, Deborah A. Gilliam, 2017 .

Pragmatic multicentre randomised controlled trial evaluating the impact of a routine molecular point-of-care ‘test-and-treat’ strategy for influenza in adults hospitalised with acute respiratory illness (FluPOC): trial protocol

Ahalya K. Malachira, T. Clark, Kate R. Beard, 2019, BMJ Open.

Neuraminidase inhibitor use in adults presenting to hospital with suspected influenza: A questionnaire-based survey of practice among hospital physicians

Ahalya K. Malachira, T. Clark, P. Lillie, 2021, Clinical Infection in Practice.

Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial

S. Ewings, Ahalya K. Malachira, T. Clark, 2017, The Lancet Respiratory Medicine.

Hospitalised adults with pneumonia are frequently misclassified as another diagnosis.

Ahalya K. Malachira, T. Clark, P. Lillie, 2019, Respiratory medicine.

Molecular point-of-care testing for respiratory viruses versus routine clinical care in adults with acute respiratory illness presenting to secondary care: a pragmatic randomised controlled trial protocol (ResPOC)

Ahalya K. Malachira, T. Clark, N. Brendish, 2017, BMC Infectious Diseases.

Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial

S. Ewings, Ahalya K. Malachira, T. Clark, 2020, The Lancet. Respiratory medicine.

Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial

S. Ewings, Ahalya K. Malachira, T. Clark, 2018, European Respiratory Journal.

Clinical impact of syndromic molecular point-of-care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trial.

Ahalya K. Malachira, T. Clark, H. Moyses, 2023, The Lancet. Infectious diseases.

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Scott A. Prentice, Tom Michael Mitchell, Deborah A. Gilliam, 2018, Lancet.

Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial

S. Ewings, Ahalya K. Malachira, T. Clark, 2017, The Lancet Respiratory Medicine.